Recovery from schizophrenia: is it possible?

Current Opinion in Psychiatry
Antonio Vita, Stefano Barlati

Abstract

Schizophrenia has a heterogeneous range of end states, from severe cases requiring repeated hospitalization to cases in which a single illness episode is followed by complete remission. The purpose of the present review is to examine recent literature on recovery in schizophrenia, focusing on the predictive factors and on the possibility to achieve it. Roughly half of schizophrenia patients recovered or significantly improved over the long term, suggesting that functional remission is possible. Several factors predict the course of schizophrenia, including demographic, clinical, and treatment characteristics, as well as socioeconomic variables. Antipsychotics are a fundamental element of schizophrenia treatment, although the available antipsychotics have significant limitations. In this context, psychosocial interventions are supported by substantial evidence of efficacy in many outcome measures and rehabilitation interventions should be considered as an evidence-based practice and need to become a part of the standard treatment of schizophrenia. As recovery is a multidimensional concept, some authors suggested that at least two areas should be taken into account: clinical remission and social functioning. Functional outcome sh...Continue Reading

References

Aug 10, 2000·Community Mental Health Journal·S Mead, M E Copeland
Jun 5, 2001·The British Journal of Psychiatry : the Journal of Mental Science·G HarrisonD Wiersma
Sep 27, 2003·The Australian and New Zealand Journal of Psychiatry·Retta AndresenPeter Caputi
May 7, 2004·Psychiatric Services : a Journal of the American Psychiatric Association·Sandra G ResnickAnthony F Lehman
Mar 3, 2005·The American Journal of Psychiatry·Nancy C AndreasenDaniel R Weinberger
Jun 9, 2005·Psychiatric Services : a Journal of the American Psychiatric Association·Robert Paul Liberman, Alex Kopelowicz
Jan 21, 2006·Acta Psychiatrica Scandinavica·J van OsJ M Kane
Sep 1, 2006·Pharmacopsychiatry·S Leucht, R Lasser
Sep 13, 2006·The Journal of Clinical Psychiatry·Michael F Green
Oct 19, 2007·Acta Psychiatrica Scandinavica·T Burns, D Patrick
Nov 21, 2007·The British Journal of Psychiatry. Supplement·Tom Burns
Nov 21, 2007·The British Journal of Psychiatry. Supplement·Stefan Priebe
Jan 30, 2008·Schizophrenia Research·Thomas L Patterson, Oscar R Leeuwenkamp
Apr 19, 2008·Clinical Psychology Review·Steven M Silverstein, Alan S Bellack
Oct 15, 2008·Current Opinion in Psychiatry·Georg Juckel, Pier Luigi Morosini
Jan 30, 2009·Schizophrenia Bulletin·Robert S KernStephen R Marder
Dec 25, 2009·CNS Drugs·Gary RemingtonOfer Agid
Jan 9, 2010·Current Opinion in Psychiatry·Amresh ShrivastavaYves Bureau
Nov 3, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Victoria BirdElizabeth Kuipers
Feb 3, 2011·Current Opinion in Psychiatry·Robin EmsleyKeneilwa Lehloenya
Jan 1, 2010·Journal of the American Psychiatric Nurses Association·Paul H LysakerKelly D Buck
May 18, 2012·The Cochrane Database of Systematic Reviews·Stefan LeuchtJohn M Davis
Jun 2, 2012·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Philip D Harvey, Martin Strassnig
Nov 23, 2012·Schizophrenia Bulletin·Erika JääskeläinenJouko Miettunen
Jan 22, 2013·Annual Review of Clinical Psychology·Kim T MueserJeffrey E Cassisi
Jan 15, 2014·The Australian and New Zealand Journal of Psychiatry·Victoria BirdMike Slade
Feb 6, 2014·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Mike SladeRob Whitley
Apr 22, 2014·Psychiatric Services : a Journal of the American Psychiatric Association·D Russell LymanMiriam E Delphin-Rittmon
Apr 30, 2014·Schizophrenia Bulletin·W Wolfgang FleischhackerPeter Woodruff
Jun 12, 2014·The Journal of Clinical Psychiatry·Robert B Zipursky
Oct 3, 2014·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Silvana GalderisiUNKNOWN Italian Network For Research on Psychoses
Feb 7, 2015·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Robert B Zipursky, Ofer Agid
Feb 26, 2015·Clinical Schizophrenia & Related Psychoses·Bruno Bertolucci OrtizRodrigo Affonseca Bressan
Mar 17, 2015·Psychiatric Services : a Journal of the American Psychiatric Association·Kim T MueserJohn M Kane
Apr 2, 2015·The Journal of Clinical Psychiatry·John M KaneDelbert G Robinson

❮ Previous
Next ❯

Citations

Jun 30, 2018·Acta Psychiatrica Scandinavica·M Strand, Y von Hausswolff-Juhlin
Apr 12, 2020·Community Mental Health Journal·Kübra İpçiMehmet B Gürcan
Sep 5, 2020·Current Psychiatry Reports·Mackenzie T Jones, Philip D Harvey
May 16, 2020·International Journal of Environmental Research and Public Health·Gabriele NibbioAntonio Vita
May 2, 2019·Frontiers in Pharmacology·Antonio VitaMassimo Gennarelli
Apr 21, 2020·BMC Medical Ethics·Mattias StrandAnna Lindblad
Sep 17, 2020·The South African Journal of Psychiatry : SAJP : the Journal of the Society of Psychiatrists of South Africa·Henmar F BothaUlla Botha
Oct 17, 2020·BMC Psychiatry·Carina TjörnstrandDavid Brunt
May 16, 2021·Brain and Behavior·Peter HuxleyRichard Warner
May 26, 2021·Drug Development and Industrial Pharmacy·Bangqing WuLi Deng
Aug 27, 2021·Frontiers in Psychiatry·María Paz García-PortillaJulio Bobes
Nov 4, 2021·European Psychiatry : the Journal of the Association of European Psychiatrists·Ana CatalanPaolo Fusar-Poli
Oct 31, 2021·Psychiatry and Clinical Neurosciences·Toshiaki OnitsukaRyota Hashimoto
Dec 28, 2021·Journal of Psychiatric and Mental Health Nursing·Pei-Yi ChaoWen-I Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here